دورية أكاديمية

FOXD1 expression-based prognostic model for uveal melanoma

التفاصيل البيبلوغرافية
العنوان: FOXD1 expression-based prognostic model for uveal melanoma
المؤلفون: Yang Luo, Renhao Ni, Xiaojun Jin, Peipei Feng, Chenyi Dai, Lingjing Jiang, Pingping Chen, Lu Yang, Yabin Zhu
المصدر: Heliyon, Vol 9, Iss 11, Pp e21333- (2023)
بيانات النشر: Elsevier, 2023.
سنة النشر: 2023
المجموعة: LCC:Science (General)
LCC:Social sciences (General)
مصطلحات موضوعية: FOXD1, Uveal melanoma, Patient survival, Treatment sensitivity, Prognostic model, Science (General), Q1-390, Social sciences (General), H1-99
الوصف: FOXD1, a new member of the FOX transcription factor family, serves as a mediator and biomarker for cell reprogramming. But its contribution to prognosis of uveal melanoma (UVM) is unclear. This study demonstrated that FOXD1 might promote tumor growth and invasion, because FOXD1 expression was negatively correlated with overall survival, progression-free survival, and disease-specific survival in UVM patients. This conjecture was verified in cell culture with human uveal melanoma cell line (MUM2B) as model cells. Additionally, the biological mechanisms of FOXD1 based on FOXD1-related genomic spectrum, molecular pathways, tumor microenvironment, and drug treatment sensitivity were examined using The Cancer Genome Atlas (TCGA) database, aiming to reasonably explain why FOXD1 leads to poor prognosis of UVM. On these bases, a novel tumor prognostic model was established using the FOXD1-related immunomodulators TMEM173, TNFRSF4, TNFSF13, and ULBP1, which will enable the stratification of disease seriousness and clinical treatment for patients.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2405-8440
Relation: http://www.sciencedirect.com/science/article/pii/S2405844023085419; https://doaj.org/toc/2405-8440
DOI: 10.1016/j.heliyon.2023.e21333
URL الوصول: https://doaj.org/article/540dacd658fd4e54b41d5e39603a17fa
رقم الأكسشن: edsdoj.540dacd658fd4e54b41d5e39603a17fa
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:24058440
DOI:10.1016/j.heliyon.2023.e21333